Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: New Zealand Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20067
20085
20094
20108
20112
20124
20131
20141
20152
20172
20182
20201
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Terminated6
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda12
Boehringer Ingelheim10
Janssen Research & Development, LLC5
Hoffmann-La Roche4
Eli Lilly and Company3
GlaxoSmithKline3
Lexicon Pharmaceuticals3
AstraZeneca2
Bayer2
Novo Nordisk A/S2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 247
Diabetes Mellitus13
Glucose Metabolism Disorders7
Dyslipidemias6
Cardiovascular Diseases5
Renal Insufficiency, Chronic4
Diabetic Nephropathies3
Hyperglycemia3
Kidney Diseases3
Glucose Intolerance2

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.